Your browser doesn't support javascript.
loading
Safety review of tenofovir disoproxil fumarate/emtricitabine pre-exposure prophylaxis for pregnant women at risk of HIV infection.
Stalter, Randy M; Pintye, Jillian; Mugwanya, Kenneth K.
Affiliation
  • Stalter RM; Epidemiology Department, University of Washington, Seattle, WA, USA.
  • Pintye J; School of Nursing, University of Washington, Seattle, WA, USA.
  • Mugwanya KK; Department of Global Health, University of Washington, Seattle, WA, USA.
Expert Opin Drug Saf ; 20(11): 1367-1373, 2021 Nov.
Article in En | MEDLINE | ID: mdl-33998936
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Type of study: Etiology_studies / Risk_factors_studies Limits: Female / Humans / Pregnancy Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Estados Unidos